Labor & Employment

Generic maker Leading Pharma recently completed a financing transaction for $40 million of growth capital. The growth capital, led by Signet Healthcare Partners and Crestline Investors, will be used to expand the Fairfield, N.J.-based company’s pipeline and pay off debt.

Perrigo on Monday announced the appointment of Uwe Röhrhoff as CEO, effective Jan. 15, following the retirement of John Hendrickson.

Diplomat Pharmacy has announced that co-founder, CEO and chairman Phil Hagerman is retiring. The Flint, Mich.-based company has named board member Jeff Park as interim CEO, effective immediately. Hagerman will continue as a member of the board and become chairman emeritus, with Ben Wolin taking over as chairman, effective immediately.

A staunch legislative advocate of the dietary supplement and over-the-counter medicine industries earlier this week announced his retirement from the Senate. On Tuesday, Sen. Orrin Hatch, R-Utah, announced on Twitter that he will not be defending his Senate seat in 2018.

Independent African-American owned Essence Ventures has announced the acquisition of the multi-platform media company Essence Communications from Time.

The New York City-based company’s current president, Michelle Ebanks will continue at the helm of the company and join its board of directors. In addition, the all Black female executive team of Essence including Ebanks will have an equity stake in the business.

As it forges ahead with its proposed acquisition of Aetna, CVS Health on Thursday shared guidance for its 2018, during which it said it expects its operating profit rise between 1% and 4%. For the retail/long-term-care area of the business, the Woonsocket, R.I.-based company said that it expects low single-digit growth, with expected low- to mid-single-digit growth in the pharmacy services segment.

Goodlettsville, Tenn.-based, Dollar General has announced plans to build its 17^th facility in its major distribution network. The company previously built its first center in San Antonio, Texas back in 2014 and celebrated the opening of a second location also within Texas in 2016.

In addition to opening this new location, the company also is looking to create 400 new jobs when at full capacity and serve 1,000 retail locations within Texas and the southeast. The structure itself is expected to be nearly 1,000,000 square feet, the company said.

Amneal Pharmaceuticals and Impax Labs have new leadership. The Bridgewater, N.J.-based Amneal has named Robert Stewart president, effective Jan. 25, 2018. Stewart was most recently COO at Allergan.